About us
The Cellular and Molecular Therapies (CMT) function within NHS Blood and Transplant (NHSBT) is responsible for the routine provision of stem cells for transplantation across England.
We are also experts in providing development and manufacturing services for Advanced Therapies Medicinal Products (ATMPs).
CMT also includes the Clinical Biotechnology Centre, which manufactures GMP-grade DNA plasmids and viral vectors.
Reasons to choose NHSBT
- Expertise: With several decades of GMP experience, CMT's advanced therapies unit delivers extensive expertise within a robust infrastructure.
- Capability: We have 6 HTA accredited laboratories, 4 of which are also MHRA accredited, with over 1,000 scientists, clinicians and doctors on hand to provide advice, support and guidance into the world of GMP production.
- End-to-end service: Our access to NHS apheresis, starting material, cell banking, cryostorage and more makes us your one stop for all GMP requirements.
- Safety: Our comprehensive understanding of and commitment to regulatory requirements guarantees compliant, safe innovation. NHSBT is integrated within the NHS, prioritising patient safety and efficacy, providing a trustworthy partnership for advancing medical treatments from conception through to clinical application.
